Jian Li Selected Research

Jian Li Research Topics

Disease

660	Neoplasms (Cancer) 12/2024 - 04/2002
260	Infections 05/2024 - 10/2002
156	Inflammation (Inflammations) 06/2024 - 12/2004
94	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2007
77	Body Weight (Weight, Body) 02/2024 - 05/2003
74	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 04/2002
67	Breast Neoplasms (Breast Cancer) 12/2024 - 01/2007
64	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2006
59	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2009
52	Hypoxia (Hypoxemia) 01/2024 - 01/2002
51	Pain (Aches) 02/2024 - 05/2005
50	Fibrosis (Cirrhosis) 05/2024 - 09/2002
47	Carcinogenesis 12/2024 - 03/2011
44	Stomach Neoplasms (Stomach Cancer) 05/2024 - 09/2007
43	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2008
42	Malaria 03/2024 - 01/2009
40	Insulin Resistance 03/2024 - 12/2007
37	Hemorrhage 04/2024 - 12/2004
37	POEMS Syndrome (Syndrome, POEMS) 11/2023 - 11/2010
36	Type 2 Diabetes Mellitus (MODY) 04/2024 - 08/2008
36	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 05/2007
36	Carcinoma (Carcinomatosis) 08/2022 - 05/2006
35	Wounds and Injuries (Trauma) 04/2024 - 06/2006
32	COVID-19 04/2024 - 01/2020
32	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 07/2010
29	Obesity 02/2024 - 09/2010
28	Thrombosis (Thrombus) 11/2023 - 02/2006
27	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 03/2005
27	Hypertension (High Blood Pressure) 12/2023 - 04/2011
26	Sepsis (Septicemia) 01/2024 - 03/2012
26	Myocardial Infarction 01/2024 - 08/2003
25	Amyloidosis 05/2024 - 06/2011
25	Thalassemia 11/2023 - 10/2003
24	Disease Progression 03/2024 - 01/2010
24	Multiple Myeloma 01/2024 - 10/2009
23	Non-alcoholic Fatty Liver Disease 05/2024 - 03/2014
23	Lymphoma (Lymphomas) 11/2023 - 01/2015
23	Esophageal Squamous Cell Carcinoma 11/2022 - 06/2007
22	Virus Diseases (Viral Diseases) 04/2024 - 11/2009
22	Necrosis 01/2024 - 09/2007
22	Atherosclerosis 11/2023 - 09/2010
22	Atrial Fibrillation 08/2022 - 08/2008
22	Respiratory Tract Infections (Respiratory Tract Infection) 07/2022 - 10/2013
21	Pneumonia (Pneumonitis) 05/2024 - 10/2007
21	Critical Illness (Critically Ill) 01/2023 - 12/2007
20	Cardiovascular Diseases (Cardiovascular Disease) 07/2024 - 11/2010
20	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 04/2000
20	Stroke (Strokes) 03/2024 - 04/2012
20	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 01/2013
19	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 05/2018

Drug/Important Bio-Agent (IBA)

224	Proteins (Proteins, Gene)FDA Link 06/2024 - 07/2002
145	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2005
89	Colistin (Coly-Mycin)FDA Link 11/2023 - 05/2003
88	MicroRNAs (MicroRNA)IBA 12/2023 - 11/2009
85	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 09/2006
78	Messenger RNA (mRNA)IBA 04/2024 - 07/2005
68	CytokinesIBA 05/2024 - 12/2004
56	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2006
52	Polymyxins (Polymyxin)IBA 12/2023 - 09/2006
51	Therapeutic UsesIBA 07/2024 - 08/2005
50	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 03/2003
48	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2024 - 12/2007
47	Long Noncoding RNAIBA 03/2024 - 01/2015
46	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2019
39	RNA (Ribonucleic Acid)IBA 03/2024 - 03/2003
37	LipidsIBA 05/2024 - 05/2009
37	AntioxidantsIBA 02/2024 - 12/2007
37	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 12/2003
35	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 03/2007
34	EnzymesIBA 01/2024 - 07/2005
33	AntigensIBA 03/2024 - 04/2002
33	VaccinesIBA 01/2023 - 04/2002
32	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 10/2009
28	Tyrosine Kinase InhibitorsIBA 11/2023 - 10/2005
27	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 01/2014
26	Polysaccharides (Glycans)IBA 04/2024 - 09/2007
25	Interleukin-6 (Interleukin 6)IBA 04/2024 - 10/2012
24	LigandsIBA 05/2024 - 01/2014
24	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2011
24	Phosphotransferases (Kinase)IBA 06/2023 - 10/2005
23	Indicators and Reagents (Reagents)IBA 05/2024 - 12/2008
23	Peptides (Polypeptides)IBA 04/2024 - 04/2004
23	LipopolysaccharidesIBA 01/2024 - 02/2011
23	Small Interfering RNA (siRNA)IBA 01/2024 - 09/2010
23	Insulin (Novolin)FDA Link 09/2023 - 12/2007
22	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2024 - 02/2006
22	Imatinib Mesylate (Gleevec)FDA Link 04/2024 - 03/2011
22	Antiviral Agents (Antivirals)IBA 04/2024 - 05/2007
22	Bortezomib (Velcade)FDA Link 03/2024 - 10/2009
21	CollagenIBA 04/2024 - 09/2002
21	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022 - 09/2007
20	ErbB Receptors (EGF Receptor)IBA 02/2022 - 01/2008
19	CateninsIBA 05/2024 - 12/2011
19	Oxygen (Dioxygen)IBA 05/2024 - 01/2012

Therapy/Procedure

394	Therapeutics 07/2024 - 07/2004
140	Drug Therapy (Chemotherapy) 05/2024 - 09/2003
57	Immunotherapy 03/2024 - 04/2010
40	Radiotherapy 02/2024 - 09/2003
21	Aftercare (After-Treatment) 09/2023 - 05/2005
20	Length of Stay 11/2023 - 11/2009